Gansu producer established on 31 July 2020 in the Lanzhou New District chemical park, combining R&D, production and sales of respiratory and digestive tract drug APIs and pharmaceutical intermediates such as vitamin D3 and omeprazole chloride, on a 264 mu site with total investment of CNY 400 million.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen